|
Volumn 31, Issue 3-6, 2001, Pages 118-122
|
Vampire bat plasminogen activator DSPA-alpha-1 (desmoteplase): A thrombolytic drug optimized by natural selection
a
Paion GmbH
(Germany)
|
Author keywords
Desmoteplase; DSPA; Fibrin specificity; Fibrinolytic; Plasminogen activator; Stroke; Thrombolytic
|
Indexed keywords
DESMOTEPLASE;
FIBRINOLYTIC AGENT;
HEPARIN;
PLASMINOGEN ACTIVATOR;
UNCLASSIFIED DRUG;
SALIVARY PLASMINOGEN ACTIVATOR ALPHA 1, DESMODUS ROTUNDUS;
TISSUE PLASMINOGEN ACTIVATOR;
ARTICLE;
BIOCHEMISTRY;
BLEEDING;
BLOOD;
BLOOD CLOTTING;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
FIBRINOLYTIC THERAPY;
HEART INFARCTION;
HEMOSTASIS;
HUMAN;
NERVE CELL PLASTICITY;
NEUROTOXICITY;
PHYSIOLOGY;
PRIORITY JOURNAL;
PROTEIN DEGRADATION;
RECOMBINANT DNA TECHNOLOGY;
SALIVA;
SIDE EFFECT;
STROKE;
THROMBOSIS;
TOXICOLOGY;
WOUND HEALING;
ANIMAL;
BAT;
CHEMISTRY;
COMPARATIVE STUDY;
GENETIC SELECTION;
REVIEW;
ANIMALS;
CHIROPTERA;
CLINICAL TRIALS;
FIBRINOLYTIC AGENTS;
HUMANS;
PLASMINOGEN ACTIVATORS;
SELECTION (GENETICS);
TISSUE PLASMINOGEN ACTIVATOR;
|
EID: 0035742590
PISSN: 03010147
EISSN: None
Source Type: Journal
DOI: 10.1159/000048054 Document Type: Article |
Times cited : (51)
|
References (13)
|